Avalon BioVentures SPV I, L.P. sold $77.4M of Janux Therapeutics (JANX)

Executed Oct 16 2024, disclosed Oct 18 2024, 2 days later.

Value, as filed

$77.4M

1,671,285 sh across 16 lots

Executed

Oct 16 2024

the trade date, as filed

Disclosed

Oct 18 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AP Avalon BioVentures SPV I, L.P. 10% owner profile →

Avalon BioVentures SPV I, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in JANX. The largest single filing was $77.4M of JANX (1,671,285 sh across 16 lots, as filed), executed Oct 16 2024.

The name

JANX JANX JANX · 18 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→